Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Good Review Management Practices To Debut In “Near Future”

This article was originally published in The Pink Sheet Daily

Executive Summary

Even as the agency wrestles with the transformation brought by FDAAA, shifts in how it processes NDAs may be the "most important," CDER official says.
Advertisement

Related Content

FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
Good Review Principles Implementation Could Threaten Six-Month Priority Review Timeframe
Good Review Principles Implementation Could Threaten Six-Month Priority Review Timeframe
FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
Drug Safety’s “Equal Voice” To Be Considered At Internal CDER Workshop
CBER Close To Filling New Hire Spots
Good Review Management Guidance Splits Responsibility Between Sponsors & FDA
Good Review Management Guidance Splits Responsibility Between Sponsors & FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS068350

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel